Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

May 30, 2025

Study Completion Date

May 31, 2025

Conditions
DepressionCognitionQuality of Life
Interventions
BEHAVIORAL

Digital neurotherapy (DNT) Treatment

The experimental group will have 8 weeks of DNT 4 times a week for 30 minutes in the participant's home. The computer-presented training will be done on the participants' tablets or personal computers with the Rejuvenate brain training program

BEHAVIORAL

Wait list control group

Waiting-list control group participants will be offered 8 weeks of DNT training at the completion of the final outcome assessment.

Trial Locations (1)

06512

Yale New Haven Hospital, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT04961047 - Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors | Biotech Hunter | Biotech Hunter